MCH ANALYSIS RESEARCHMain site ↗
Theme

Artificial Intelligence & Compute

The AI compute and infrastructure complex — silicon, cloud and the platforms monetising it.

47 covered names · ranked by fair value vs price
Equity Research

Cirrus Logic Inc (CRUS)

BUY. 12-month probability-weighted target $133 (+24% vs spot). P/E Multiple explains 69% of Monte Carlo outcome variance.

CRUSEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +32.0%
Equity Research

Cerebras Systems Inc. Class A Common Stock (CBRS)

BUY. 12-month probability-weighted target $206 (+25% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

CBRSEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +21.3%
Equity Research

First Solar Inc. (FSLR)

BUY. 12-month probability-weighted target $230 (+29% vs spot). P/E Multiple explains 71% of Monte Carlo outcome variance.

FSLREquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +18.0%
Equity Research

Snap Inc. (SNAP)

HOLD. 12-month probability-weighted target $6 (-4% vs spot). Snap Inc. (SNAP) — quantitative single-name research from MCH Analysis.

SNAPEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price +17.7%
Equity Research

Amkor Technology Inc (AMKR)

BUY. 12-month probability-weighted target $61 (+24% vs spot). Gross Margin explains 57% of Monte Carlo outcome variance.

AMKREquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +14.0%
Equity Research

NXP Semiconductors NV (NXPI)

HOLD. 12-month probability-weighted target $263 (+15% vs spot). P/E Multiple explains 76% of Monte Carlo outcome variance.

NXPIEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price +12.7%
Equity Research

KLA Corporation (KLAC)

BUY. 12-month probability-weighted target $245 (+25% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

KLACEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +7.2%
Equity Research

Qnity Electronics, Inc (Q)

BUY. 12-month probability-weighted target $151 (+19% vs spot). P/E Multiple explains 65% of Monte Carlo outcome variance.

QEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +6.3%
Equity Research

Allegro Microsystems Inc (ALGM)

BUY. 12-month probability-weighted target $46 (+29% vs spot). P/E Multiple explains 68% of Monte Carlo outcome variance.

ALGMEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +6.3%
Equity Research

ON Semiconductor Corporation (ON)

HOLD. 12-month probability-weighted target $87 (+12% vs spot). P/E Multiple explains 73% of Monte Carlo outcome variance.

ONEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price +6.1%
Equity Research

Qualcomm Incorporated (QCOM)

HOLD. 12-month probability-weighted target $174 (-1% vs spot). P/E Multiple explains 73% of Monte Carlo outcome variance.

QCOMEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price +5.7%
Equity Research

Universal Display (OLED)

HOLD. 12-month probability-weighted target $79 (+5% vs spot). P/E Multiple explains 77% of Monte Carlo outcome variance.

OLEDEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price +5.7%
Equity Research

Microchip Technology Inc (MCHP)

HOLD. 12-month probability-weighted target $83 (+9% vs spot). P/E Multiple explains 79% of Monte Carlo outcome variance.

MCHPEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price +4.7%
Equity Research

Enphase Energy Inc (ENPH)

HOLD. 12-month probability-weighted target $34 (+4% vs spot). P/E Multiple explains 67% of Monte Carlo outcome variance.

ENPHEquity ResearchMonte Carlo
11 October 2026Rating: HOLD · Fair value vs price +3.4%
Equity Research

Applied Materials Inc (AMAT)

HOLD. 12-month probability-weighted target $621 (+23% vs spot). P/E Multiple explains 79% of Monte Carlo outcome variance.

AMATEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -1.2%
Equity Research

Qorvo Inc (QRVO)

HOLD. 12-month probability-weighted target $114 (-1% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

QRVOEquity ResearchMonte Carlo
11 October 2026Rating: HOLD · Fair value vs price -1.3%
Equity Research

MKS Instruments Inc (MKSI)

HOLD. 12-month probability-weighted target $285 (+8% vs spot). P/E Multiple explains 68% of Monte Carlo outcome variance.

MKSIEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -5.0%
Equity Research

Advanced Energy Industries Inc (AEIS)

HOLD. 12-month probability-weighted target $277 (-4% vs spot). P/E Multiple explains 71% of Monte Carlo outcome variance.

AEISEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -6.8%
Equity Research

Skyworks Solutions Inc (SWKS)

SELL. 12-month probability-weighted target $66 (-13% vs spot). P/E Multiple explains 65% of Monte Carlo outcome variance.

SWKSEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -6.9%
Equity Research

NVIDIA Corporation (NVDA)

SELL. 12-month probability-weighted target $199 (-13% vs spot). Revenue Growth explains 59% of Monte Carlo outcome variance.

NVDAEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -7.5%
Equity Research

Texas Instruments Incorporated (TXN)

HOLD. 12-month probability-weighted target $276 (-3% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

TXNEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -8.3%
Equity Research

Meta Platforms (META)

SELL. 12-month probability-weighted target $569 (-21% vs spot). P/E Multiple explains 71% of Monte Carlo outcome variance.

METAEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -8.4%
Equity Research

Rambus Inc (RMBS)

SELL. 12-month probability-weighted target $98 (-9% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

RMBSEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -8.6%
Equity Research

Akamai Technologies Inc (AKAM)

HOLD. 12-month probability-weighted target $111 (+4% vs spot). P/E Multiple explains 73% of Monte Carlo outcome variance.

AKAMEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -9.3%
Equity Research

Lam Research Corp (LRCX)

HOLD. 12-month probability-weighted target $309 (-3% vs spot). P/E Multiple explains 72% of Monte Carlo outcome variance.

LRCXEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -10.4%
Equity Research

Analog Devices Inc (ADI)

HOLD. 12-month probability-weighted target $375 (-8% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

ADIEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -11.5%
Equity Research

Onto Innovation Inc (ONTO)

HOLD. 12-month probability-weighted target $272 (-8% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

ONTOEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -12.2%
Equity Research

FormFactor Inc (FORM)

HOLD. 12-month probability-weighted target $150 (+7% vs spot). P/E Multiple explains 74% of Monte Carlo outcome variance.

FORMEquity ResearchMonte Carlo
11 October 2026Rating: HOLD · Fair value vs price -12.9%
Equity Research

Synaptics Incorporated (SYNA)

HOLD. 12-month probability-weighted target $109 (-9% vs spot). P/E Multiple explains 61% of Monte Carlo outcome variance.

SYNAEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -15.1%
Equity Research

VeriSign Inc (VRSN)

SELL. 12-month probability-weighted target $252 (-17% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

VRSNEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -18.3%
Equity Research

MACOM Technology Solutions Holdings Inc (MTSI)

SELL. 12-month probability-weighted target $266 (-19% vs spot). P/E Multiple explains 83% of Monte Carlo outcome variance.

MTSIEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -21.6%
Equity Research

Godaddy Inc (GDDY)

SELL. 12-month probability-weighted target $83 (-21% vs spot). P/E Multiple explains 68% of Monte Carlo outcome variance.

GDDYEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -23.0%
Equity Research

Alphabet Inc. (GOOGL)

SELL. 12-month probability-weighted target $286 (-19% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

GOOGLEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -23.3%
Equity Research

Monolithic Power Systems Inc (MPWR)

SELL. 12-month probability-weighted target $1179 (-15% vs spot). P/E Multiple explains 83% of Monte Carlo outcome variance.

MPWREquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -26.5%
Equity Research

Lattice Semiconductor Corporation (LSCC)

SELL. 12-month probability-weighted target $113 (-10% vs spot). P/E Multiple explains 83% of Monte Carlo outcome variance.

LSCCEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -29.2%
Equity Research

Teradyne Inc (TER)

SELL. 12-month probability-weighted target $353 (-12% vs spot). P/E Multiple explains 75% of Monte Carlo outcome variance.

TEREquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -29.9%
Equity Research

Entegris Inc (ENTG)

SELL. 12-month probability-weighted target $131 (-21% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

ENTGEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -31.9%
Equity Research

Marvell Technology Group Ltd (MRVL)

SELL. 12-month probability-weighted target $227 (-17% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

MRVLEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -36.5%
Equity Research

Semtech Corporation (SMTC)

SELL. 12-month probability-weighted target $123 (-34% vs spot). P/E Multiple explains 75% of Monte Carlo outcome variance.

SMTCEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -39.0%
Equity Research

Intel Corporation (INTC)

SELL. 12-month probability-weighted target $82 (-21% vs spot). P/E Multiple explains 55% of Monte Carlo outcome variance.

INTCEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -40.0%
Equity Research

Advanced Micro Devices Inc (AMD)

SELL. 12-month probability-weighted target $411 (-32% vs spot). P/E Multiple explains 78% of Monte Carlo outcome variance.

AMDEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -48.0%
Equity Research

Sitime Corporation (SITM)

Rating suspended since 2026-09-29 — valuation method under review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

SITMEquity ResearchMonte Carlo
10 October 2026Rating: N/A
Equity Research

Micron Technology (MU)

Rating suspended since 2026-09-21 — valuation input under review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

MUEquity ResearchMonte Carlo
10 October 2026Rating: N/A
Equity Research

DigitalOcean Holdings Inc (DOCN)

Rating suspended since 2026-09-29 — valuation method under review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

DOCNEquity ResearchMonte Carlo
10 October 2026Rating: N/A
Equity Research

Broadcom Inc (AVGO)

Rating suspended since 2026-10-01 — under analyst review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

AVGOEquity ResearchMonte Carlo
10 October 2026Rating: N/A
Equity Research

Silicon Laboratories Inc (SLAB)

Rating suspended since 2026-10-10 — pending acquisition. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

SLABEquity ResearchMonte Carlo
30 July 2026Rating: N/A
Single-name · Consumer Tech

AAPL: a real growth inflection — but the stock has already paid for it

iPhone +22%, China +30%, Services at a record. Real inflection — but triangulated fair value (~$279) sits just below spot. HOLD.

AAPLAppleConsumer TechAI
15 June 2026AAPL
MCH ANALYSIS · All research · Research, not personal financial advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.20.0 · US-listed

MCH Analysis is a general investment-research publication of MCH Advisory (Pty) Ltd. It is not personal financial advice and does not take your circumstances into account. MCH is not a licensed financial services provider or a registered investment adviser. Past performance, whether actual or simulated, does not predict future results. Subscriber Agreement | Privacy and Cookie Notice | Research Governance Policies